+20.1%
GSK vs VEU
+23.8%
-3.7%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VEU | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +1.0% | -1.0% | -0.3% |
| 7D | -3.5% | -1.4% | -2.1% | -3.1% |
| 30D | -3.4% | -0.4% | -3.0% | -3.3% |
| 3M | -8.1% | +2.5% | -10.7% | -9.0% |
| 6M | -11.1% | +11.1% | -22.3% | -15.6% |
| YTD | +0.7% | +16.5% | -15.8% | -6.3% |
| 1Y | +20.1% | +22.9% | -2.8% | +7.6% |
| All | +20.1% | +23.8% | -3.7% | +7.6% |
Cumulative growth
Daily Returns
Daily percentage return beside VEU.
Daily Out/Under-Performance
Portfolio return minus VEU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VEU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling